−870 KRW
−12.06 B KRW
323.87 M KRW
18.30 M
About APTABIO THERAPEUTICS INC.
Sector
CEO
Su-Jin Lee
Headquarters
Yongin-si
Website
Founded
2009
ISIN
KR7293780003
FIGI
BBG00P2BVY44
Aptabio Therapeutics, Inc. is a pharmaceutical biotechnology company, which engages in the development of intractable innovative drugs based on original platform technology. It operates through the Product Sales and Other Sales divisions. The company was founded by Su-Jin Lee on July 24, 2009 and is headquartered in Yongin-si, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 293780 is 7,060 KRW — it has decreased by −1.67% in the past 24 hours. Watch APTABIO THERAPEUTICS INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange APTABIO THERAPEUTICS INC. stocks are traded under the ticker 293780.
293780 stock has risen by 3.98% compared to the previous week, the month change is a 11.71% rise, over the last year APTABIO THERAPEUTICS INC. has showed a −3.95% decrease.
293780 reached its all-time high on Sep 6, 2021 with the price of 62,100 KRW, and its all-time low was 4,930 KRW and was reached on May 27, 2024. View more price dynamics on 293780 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
293780 stock is 7.15% volatile and has beta coefficient of 1.46. Track APTABIO THERAPEUTICS INC. stock price on the chart and check out the list of the most volatile stocks — is APTABIO THERAPEUTICS INC. there?
Today APTABIO THERAPEUTICS INC. has the market capitalization of 189.78 B, it has decreased by −0.43% over the last week.
Yes, you can track APTABIO THERAPEUTICS INC. financials in yearly and quarterly reports right on TradingView.
293780 net income for the last quarter is −8.03 B KRW, while the quarter before that showed −7.03 B KRW of net income which accounts for −14.13% change. Track more APTABIO THERAPEUTICS INC. financial stats to get the full picture.
No, 293780 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 25, 2025, the company has 30.00 employees. See our rating of the largest employees — is APTABIO THERAPEUTICS INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. APTABIO THERAPEUTICS INC. EBITDA is −19.43 B KRW, and current EBITDA margin is −5.05 K%. See more stats in APTABIO THERAPEUTICS INC. financial statements.
Like other stocks, 293780 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade APTABIO THERAPEUTICS INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So APTABIO THERAPEUTICS INC. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating APTABIO THERAPEUTICS INC. stock shows the sell signal. See more of APTABIO THERAPEUTICS INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.